###### Strengths and limitations of this study

-   The nation-wide study on process indicators of primary healthcare (PHC) covered all general medical practices in Hungary responsible for the provision to adults, avoided selection bias.

-   Our investigation could estimate the population-level impact of the general practitioner (GP) gender effect.

-   Although the analyses were controlled for several factors (GP age; patient age, gender, relative education; and practice size, types of settlement and regional location) influencing the quality of PHC, by involving other potential confounding factors (such as onset/duration of a chronic diseases, preferences and conditions of patients), reliability of our estimations for risks and impacts could be further improved.

Introduction {#s1}
============

The gender composition of physicians has changed in the last decades in all organisation for economic co-operation and development (OECD) countries. The proportion of female physicians has increased from 38% (in 2000) to 46% (in 2015), and this trend is expected to continue.[@R1] The Central and Eastern European countries showed the highest share of female physicians in 2015. Extremes of this share were observed in Latvia (74.4%) and in Estonia (74.6%), but the strongest growing trend was in the Netherlands, where the proportion of female physicians increased from 35.3% to 52.6% from 2000 to 2015. However, changes in gender proportions are not homogeneous in the different medical specialties; some, such as family medicine, are more affected.[@R1]

According to the international literature, there is solid evidence that the physician's gender influences the effectiveness of medical care in primary healthcare (PHC).[@R5] Female physicians in primary care tend to deliver more preventive services,[@R10] they have better adherence to guidelines of chronic diseases[@R8] and they achieve better intermediate treatment outcomes (blood pressure, haemoglobin A1c (HbA1c) and cholesterol level), compared with their male colleagues.[@R20]

Several arguments could partially explain the existing differences between the quality of services provided by the two genders. Female physicians more often use patient-centred approach; moreover, they effectively facilitate patient participation in the medical exchange.[@R8] According to studies in clinical practice, female physicians spend significantly more time with their patients and have longer consultations.[@R6] Others have underlined the significance of the patient-centred communication style, which is more frequently applied by female physicians.[@R8] Empathy is a further aspect of physicians' behaviour associated with better patient compliance and outcomes in chronic disease care[@R23] and a higher level of empathy is a well-known characteristic of women.[@R32] Additionally, the level of empathy seems to have an impact on career choices; individuals with higher empathy tend to prefer the primary care specialty.[@R30] Similar specialty preference was found among both medical students and physicians.[@R30]

The association between the gender of the provider (especially general practitioners (GPs)) and the effectiveness of the service is well demonstrated in many settings, but the exploration of how the gender of the physician actually affects the care practices and assessments of the size of the effect are insufficient.

Hungary provides an ideal field to examine the gender effect at the level of primary care in detail. The country has one of the highest shares of female physicians of general medicine and paediatrics, with a total share of 55.9% in 2015[@R1] and 56.2% in 2017.[@R35] In Hungary, the gender of the GP can be used as a potential factor affecting general medical practice (GMP)-level performance indicators because each individual GP works in their own primary care district with a territorial supply obligation (municipalities are responsible for the provision of primary care for the local population within their territory). Since 2009, the performance of providers has been monitored for quality indicators by the National Institute of Health Insurance Fund Management (NIHIFM), which have contracts with all GPs in the country. This monitoring exclusively applies process indicators to assess the quality of chronic disease management in primary care. The evaluation of GMPs and the provision of financial incentives are based on reaching desired target values for these indicators.[@R36]

The objectives of our study were (1) to investigate the association between GP gender and the quality of primary care with respect to various process indicators for GMP performance and (2) to assess the size of the gender impact.

Methods {#s2}
=======

Setting {#s2-1}
-------

The healthcare system in Hungary is based on compulsory health insurance with universal coverage. Primary care services are provided by GPs working in solo practices; therefore, one GMP is owned and operated by one GP. In vacant GMPs, the services are provided by temporary GPs with restricted availability in time and place. The GPs are contracted with the NIHIFM, and they have territorial supply obligation, but patients can choose and change their primary care provider without any restriction.[@R37]

Study design {#s2-2}
------------

A nation-wide cross-sectional study was performed, which covered all GMPs in Hungary responsible for the adult primary care in 2016 (n=4852). Demographic data of 7 207 186 clients (above 18 years) and 4575 GPs, the GMPs' organisational characteristics and data on performance indicators for GMPs were provided by NIHIFM. Vacant GMPs without a permanent GP during the study period (5.71%, n=277) were excluded, as this secondary analysis aimed to evaluate the influence of GPs' gender on PHC indicators.

Patient and public involvement {#s2-3}
------------------------------

Patients and the public were not involved in this study.

Patient-level, physician-level and organisational characteristics of GMPs {#s2-4}
-------------------------------------------------------------------------

Patient-specific and GMP-specific data were provided by NIHIFM. The number of adults registered in each GMP was determined by gender and age groups of 18--19, 20--24, 25--29, 30--34, 35--39, 40--44, 45--49, 50--54, 55--59, 60--64, 65--69, 70--74, 75--79, 80--84, 85--89, and 90 years and above in the database. The age group of 65--69 (and 60--64 where 65 years and above patients were not available) was used as a reference. The age of the GP was a continuous variable. The male gender of GPs and patients were used as a reference in the analyses.

GMPs were categorised by the practice size (number of insured people registered in each GMP as follows:\<800, 801--1200, 1201--1600, 1601--2000 and \>2000; the categories are defined by NIHIFM), and types of settlement (rural and urban). The regional location of each GMP was described by the county (Baranya, Bács-Kiskun, Békés, Borsod-Abaúj-Zemplén, Csongrád, Fejér, Győr-Moson-Sopron, Hajdú-Bihar, Heves, Komárom-Esztergom, Nógrád, Pest, Somogy, Szabolcs-Szatmár-Bereg, Jász-Nagykun-Szolnok, Tolna, Vas, Veszprém and Zala counties) and the capital city (Budapest). The practice size of 1201--1600, the rural settlement and Budapest were used as reference categories.

The relative education was used to indicate the educational attainment of adults registered in each GMP. This indicator was calculated using gender, age group (7--19, 20--24, 25--29, 30--34, 35--39, 40--44, 45--49, 50--54, 55--59, 60--64, 65--69, 70--74, 75--79, 80--84, 85--89 and 90 years and above), and settlement-specific data from 2011 Hungarian Census data provided by the Hungarian Central Statistical Office. The summarised length of education was calculated for each settlement. The expected number of school years was determined for adults in each settlement by the demographic characteristics of the settlement and the national reference values. The ratio of observed and expected values, representing the settlement-specific relative education, was used to express the relative education of adults living in a certain settlement compared with the national reference level. A weighted settlement-specific relative education variable was calculated for GMPs providing care for patients from more than one settlement.[@R38]

Performance indicators for GMPs {#s2-5}
-------------------------------

Each routine indicator of NIHIFM on immunisation, cancer screening and chronic disease management were used to assess the performance of GMPs: (1) proportion of patients with influenza immunisation; (2) proportion of patients who participated in screening mammography; (3) proportion of patients with hypertension with serum creatinine measurements; (4) proportion of patients with diabetes and/or hypertension with lipid profile measurements; (5) proportion of beta-blocker use among patients with ischaemic heart disease; (6) proportion of patients with diabetes with HbA1c measurements; (7) proportion of patients with diabetes who attended eye examination and (8) proportion of patients with chronic obstructive pulmonary disease (COPD) who participated in pulmonary functional testing. A composite indicator (proportion of patients who received recommended care) was calculated by summarising the number of care events and the size of the target groups by each studied indicator. Indicators reflect the proportion of patients who received the care in each GMP. Details about the target groups and definitions of the assessed process indicators are shown in [table 1](#T1){ref-type="table"}.

###### 

Definition and the target group of the studied PHC indicators

  Indicator                      Target group                                                                                                                           Definition
  ------------------------------ -------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Influenza immunisation         Patients over 65 years                                                                                                                 Proportion of PHC patients, age 65 years and older, who received an influenza immunisation in the previous 12 months
  Mammography screening          45--65 years-old female PHC patients                                                                                                   Proportion of female PHC patients, age 45--65 years, who received mammography in the previous 24 months
  Serum creatinine measurement   Patients who redeemed antihypertensive drug at least four times in the previous 12 months (considered as patients with hypertension)   Proportion of PHC patients with hypertension screened for serum creatinine in the previous 12 months
  Lipid measurement              Patients who redeemed antihypertensive drug at least four times in the previous 12 months (considered as patients with hypertension)   Proportion of PHC patients with hypertension and/or diabetes screened for lipid abnormalities in the previous 12 months
  Beta-blocker application       Patients with AMI or CABG or PTCA                                                                                                      Proportion of patients with AMI, CABG or PTCA who used beta-blockers in the previous 12 months
  HbA1c measurement              ATC A10 drug users                                                                                                                     Proportion of PHC patients with diabetes mellitus screened for HbA1c in the previous 12 months
  Eye examination                ATC A10 drug users                                                                                                                     Proportion of PHC patients with diabetes mellitus who attended eye examination in the previous 12 months
  Management of COPD             ATC R03 drug users and patients with COPD                                                                                              Proportion of PHC patients with COPD who attended pulmonary function testing in the previous 12 months
  Composite indicator            Total number of patients of each studied indicator                                                                                     Proportion of PHC patients provided with recommended care; a general indicator of performance of GMP by summarising the number of care events and size of target populations of each studied indicator

AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; GMP, general medical practice; HbA1c, haemoglobin A1c; PHC, primary healthcare; PTCA, percutaneous transluminal coronary angioplasty.

Statistical analysis {#s2-6}
--------------------

Differences between baseline characteristics of GMPs were evaluated by the Pearson χ^2^ test for categorical variables and two-sample t-test for continuous variables.

We used multilevel logistic regression models because of the binary outcome variables and in order to account for the clustering effect of patients within physicians. The models were adjusted for characteristics of patients (age and gender), GPs (age) and GMPs (practice size, types of settlement, geographical location and relative education) to assess the effect of the gender of the GP on their performance in case of each indicator. ORs with the corresponding 95% CIs, and robust standard errors were estimated. We presented intraclass correlation coefficient, which shows the proportion of total variance explained by the physician as grouping factor. The Hosmer-Lemeshow test was used to determine the goodness of fit of the model (by comparing predicted and observed outcomes in deciles of predicted risk), which verified the adequacy of the model.

We calculated the missed care events, that is the number of care events not meeting the number of events which would be expected if the care was provided by female GP. The expected number of care events was calculated for GMPs with male GPs, using the demographic composition of adults belong to GMPs and considering female GPs as a reference, to describe the gender impact on service use in the whole country. Both observed and expected number of events were summarised for the whole country. The differences between the summarised observed and expected number of care events were calculated for GMPs with male GPs to quantify the differences in the number of care events compared with female GPs. Attributable proportion (AP) with 95% CI was also calculated by the summarised number of events to show the percentage of care events that can be attributed to the male GP gender.

Statistical significance was considered p\<0.05. Statistical analyses were performed using STATA IC V.13.0 software.

Results {#s3}
=======

Descriptive statistics {#s3-1}
----------------------

The studied 4575 GPs (providing care for adults) consisted of 2213 (48.4%) women, and 2362 (51.6%) men (p\<0.001). Female GPs were younger (55.3 years vs 57.8 years; p\<0.001), more likely to work in urban regions (75.8% vs 62.0%; p\<0.001) and had smaller sized GMPs (p\<0.001). Patients of female physicians were more likely to be female (54.6% vs 52.31%; p\<0.001). The mean relative education was higher in GMPs with female GPs (1.026 vs 0.989; p\<0.001). The patient, physician and organisational characteristics of GMPs are summarised in [table 2](#T2){ref-type="table"}.

###### 

Patient-level, physician-level and organisational characteristics of GMPs

                                   All GMPs            GMPs with male GPs   GMPs with female GPs   P value
  -------------------------------- ------------------- -------------------- ---------------------- ---------
  Number of GMPs                   n=4575              n=2362 (51.6%)       n=2213 (48.4%)         
  Age of GP, mean (SD)             56.6 (11.2)         57.8 (11.3)          55.3 (10.9)            \<0.001
  Number GMPs' patients                                                                            
   Male                            3 360 154 (46.6%)   1 794 560 (47.7%)    1 565 594 (45.5%)      \<0.001
   Female                          3 847 032 (53.4%)   1 968 309 (52.3%)    1 878 723 (54.6%)      
   Total                           7 207 186           3 762 869            3 444 317              
  Age (years) groups of patients                                                                   
   18--19                          121 802 (1.69%)     67 609 (1.8%)        54 193 (1.57%)         \<0.001
   20--24                          483 058 (6.7%)      256 773 (6.82%)      226 285 (6.57%)        
   25--29                          539 957 (7.49%)     280 817 (7.46%)      259 140 (7.52%)        
   30--34                          553 972 (7.69%)     283 279 (7.53%)      270 693 (7.86%)        
   35--39                          690 907 (9.59%)     352 765 (9.37%)      338 142 (9.82%)        
   40--44                          752 110 (10.44%)    389 203 (10.34%)     362 907 (10.54%)       
   45--49                          647 431 (8.98%)     339 710 (9.03%)      307 721 (8.93%)        
   50--54                          534 270 (7.41%)     284 021 (7.55%)      250 249 (7.27%)        
   55--59                          561 965 (7.8%)      298 506 (7.93%)      263 459 (7.65%)        
   60--64                          665 236 (9.23%)     347 758 (9.24%)      317 478 (9.22%)        
   65--69                          542 777 (7.53%)     283 530 (7.53%)      259 247 (7.53%)        
   70--74                          416 851 (5.78%)     215 507 (5.73%)      201 344 (5.85%)        
   75--79                          316 345 (4.39%)     165 255 (4.39%)      151 090 (4.39%)        
   80--84                          213 912 (2.97%)     111 762 (2.97%)      102 150 (2.97%)        
   85--89                          117 420 (1.63%)     61 119 (1.62%)       56 301 (1.63%)         
   \>90                            49 322 (0.68%)      25 378 (0.67%)       23 944 (0.7%)          
  Relative education, mean (SD)    1.000 (0.1)         0.989 (0.2)          1.026 (0.1)            \<0.001
  Types of settlement                                                                              
   Urban                           3143 (68.7%)        1465 (62.0%)         1678 (75.8%)           \<0.001
   Rural                           1432 (31.3%)        897 (37.9%)          535 (24.2%)            
  GMP size (number of patients)                                                                    
   \<800                           126 (2.8%)          66 (2.9%)            60 (2.7%)              \<0.001
   801--1200                       646 (14.1%)         322 (13.6%)          324 (14.6%)            
   1201--1600                      1464 (32.0%)        690 (29.2%)          774 (34.9%)            
   1601--2000                      1415 (30.9%)        742 (31.4%)          673 (30.4%)            
   \>2000                          924 (20.2%)         542 (22.9%)          382 (17.3%)            

GMP, general medical practice; GP, general practitioner.

Female GPs were younger. In the group of female GPs under 55 years and male GPs above 65 years were over-represented (**[figure 1](#F1){ref-type="fig"}**).

![The age and gender distribution of Hungarian GPs responsible for the adult primary healthcare in 2016. GPs, general practitioners.](bmjopen-2018-027296f01){#F1}

According to the crude values of the PHC indicators (aggregated by the gender of the GP), statistically significant differences were found between male and female physicians. Patients of female GPs were more likely to have had serum creatinine (70.9% vs 66.5%; p\<0.001), lipid (64.5% vs 59.7%; p\<0.001) and HbA1c (80.6% vs 76.8%; p\<0.001) measurements; ophthalmological examinations (41.3% vs 38.2%; p\<0.001); and mammography screening (46.7% vs 44.7%; p\<0.001). They were also more likely to be managed properly in cases of COPD (79.1% vs 77.3%; p\<0.001). Although there was statistically significant differences between genders related to vaccination against influenza (p=0.004), the size of difference was negligible (20.1% vs 19.9%). Patients with male GPs were more likely to receive beta-blockers (52.3% vs 53.5%; p\<0.001) ([table 3](#T3){ref-type="table"}).

###### 

The number of patients received the care, the number of people in the target groups and the proportion of patients received the care in 2016 for the whole country by gender of GPs with 95% CIs

                                 Number of patients received the care   Number of people in target group   Proportion of patients received the care                                                       
  ------------------------------ -------------------------------------- ---------------------------------- ------------------------------------------ ----------- ------------------- ------------------- ---------
  Influenza immunisation         172 150                                159 893                            865 187                                    796 380     19.9%(19.8--19.9)   20.1%(19.9--20.2)   0.004
  Mammography screening          304 907                                299 137                            681 141                                    640 293     44.7%(44.6--44.9)   46.7%(46.5--46.9)   \<0.001
  Serum creatinine measurement   814 819                                785 950                            1 225 158                                  1 108 168   66.5%(66.4--66.6)   70.9%(70.8--71.0)   \<0.001
  Lipid measurement              752 737                                735 502                            1 261 490                                  1 139 843   59.7%(59.6--59.8)   64.5%(64.4--64.6)   \<0.001
  Beta-blocker application       48 202                                 42 184                             90 112                                     80 723      53.5%(53.2--53.8)   52.3%(51.9--52.6)   \<0.001
  HbA1c measurement              192 370                                179 474                            250 575                                    222 690     76.8%(76.6--76.9)   80.6%(80.4--80.8)   \<0.001
  Eye examination                95 617                                 91 995                             250 575                                    222 690     38.2%(37.9--38.4)   41.3%(41.1--41.5)   \<0.001
  Management of COPD             75 154                                 69 835                             97 213                                     88 345      77.3%(77.1--77.6)   79.1%(78.8--79.3)   \<0.001
  Composite indicator            2 455 956                              2 363 970                          4 721 451                                  4 299 132   52.0%(51.9--52.1)   54.9%(54.9--55.0)   \<0.001

COPD, chronic obstructive pulmonary disease; GPs, general practitioners; HbA1c, haemoglobin A1c.

Multilevel analyses {#s3-2}
-------------------

According to the multilevel logistic regression analysis, patients of female GPs were significantly more likely to receive care according to guidelines. The female gender of GPs was associated with hypertension and diabetes care-related indicators (HbA1c measurement, serum creatinine measurement, lipid measurement and eye examination), mammography screening, management of COPD patients and the composite indicator. No association was observed between influenza immunisation, beta-blocker application and GP gender. The proportion of total variability attributable to physician after adjusting for characteristics of physician, patient and practice varied between 2.4% and 17.9% across the indicators ([table 4](#T4){ref-type="table"}). Gender had one of the strongest effects among all studied variables on hypertension and diabetes care indicators (HbA1c, serum creatinine and lipid measurement). Results of the regression models are presented in [Supplementary Table 1-2](#SP1 SP2){ref-type="supplementary-material"}.

###### 

Influence of female gender of GPs (OR, 95% CIs, robust standard errors) on the primary healthcare indicators according to multilevel logistic regression analysis controlled for age of GP, age and gender of the patients, relative education of patients, practice size, types of settlement and regional location of GMP in 2016 and the ICC of tested models

  Indicators                                 OR     95% CI         Robust SE   ICC (%)
  ------------------------------------------ ------ -------------- ----------- ---------
  Influenza immunisation (over 65 years)     1.03   0.98 to 1.09   0.028       17.9
  Mammography screening (age 45--65 years)   1.05   1.03 to 1.08   0.014       4.8
  Serum creatinine measurement               1.14   1.12 to 1.17   0.014       4.1
  Lipid measurement                          1.14   1.11 to 1.16   0.014       4.6
  Beta-blocker application                   0.98   0.96 to 1.01   0.013       2.4
  HbA1c measurement                          1.18   1.14 to 1.23   0.022       8.4
  Eye examination                            1.06   1.03 to 1.08   0.013       3.3
  Management of COPD                         1.05   1.01 to 1.09   0.019       4.9
  Composite indicator                        1.08   1.07 to 1.10   0.008       1.8

Reference group is male GPs.

COPD, chronic obstructive pulmonary disease; GMP, general medical practice; GPs, general practitioners; HbA1c, haemoglobin A1c; ICC, intraclass correlation coefficient.

Population-level impact {#s3-3}
-----------------------

Overall, 5.9% (95% CI 5.77% to 6.02%) of missed care events are attributable to male GP gender, which corresponds to 144 871 care events in the country per year. Restricting this summary to indicators with a significant association with GP gender (omitting influenza vaccination and beta-blocker application), the missed number of interventions was 144 373.

Compared with the GMPs with female GPs, the highest AP was observed for lipid measurement (AP=7.93%, 95% CI 7.71% to 8.16%), whereas the lowest AP was observed for influenza immunisation (AP=0.97%, 95% CI 0.49% to 1.44%). A notable percentage of missed care events was attributed to GPs' male gender in the case of serum creatinine measurement (AP=6.4%, 95% CI 6.18% to 6.61%), eye examinations (AP=8.04%, 95% CI 7.4% to 8.67%) and HbA1c measurements (AP=5.09%, 95% CI 4.65% to 5.54%). Mammography screening was not performed for 4.36% (95% CI 4.00% to 4.71%) of women in the target group, whereas COPD management was missed for 2.33% (95% CI 1.61% to 3.04%) of patients if the GP was male. Only beta-blocker application showed more care events that were attributed to male gender of GPs (AP=2.42%, 95% CI 1.53% to 3.31%) ([table 5](#T5){ref-type="table"}).

###### 

Number of observed and expected care events in 2016, with absolute differences and attributable proportion estimations (with 95% CI) in Hungary among 3 762 869 patients provided by male GPs

  Indicators                     Number of observed cases   Number of expected cases   Absolute difference   Attributable proportion
  ------------------------------ -------------------------- -------------------------- --------------------- -------------------------
  Influenza immunisation         172 150                    173 813                    −1 663                0.97% (0.49%--1.44%)
  Screening mammography          304 907                    318 192                    −13 285               4.36% (4%--4.71%)
  Serum creatinine measurement   814 819                    866 949                    −52 130               6.4% (6.18%--6.61%)
  Lipid measurement              752 737                    812 459                    −59 723               7.93% (7.71%--8.16%)
  Beta-blocker application       48 202                     47 037                     1 165                 2.42% (1.53%--3.31%)
  HbA1c measurement              192 370                    202 170                    −9 801                5.09% (4.65%--5.54%)
  Eye examination                95 617                     103 302                    −7 686                8.04% (7.4%--8.67%)
  Management of COPD             75 154                     76 901                     −1 748                2.33% (1.61%--3.04%)
  Total (composite indicator)    2 455 956                  2 600 827                  −144 871              5.9% (5.77%--6.02%)

COPD, chronic obstructive pulmonary disease; GPs, general practitioners; HbA1c, haemoglobin A1c.

Discussion {#s4}
==========

Main findings {#s4-1}
-------------

Our results showed that GP gender was independently associated with quality of care with respect to process indicators for cancer screening and the management of chronic diseases (hypertension, diabetes and COPD). Patients of female GPs were more likely to have their HbA1c levels, serum creatinine, lipid measured, as well as their ophthalmological examination and pulmonary function testing implemented for monitoring purposes. Moreover, female patients of female GPs received significantly more mammography. Gender effect seems to have a clinical relevance mostly on hypertension and diabetes care-related indicators, considering both the higher effect of the GP\'s gender (HbA1c measurement: OR=1.18, 95% CI 1.14 to 1.23, serum creatinine: OR=1.14, 95% CI 1.12 to 1.17 and lipid measurement: OR=1.14, 95% CI 1.11 to 1.16) and size of the affected population compared with other indicators (mammography screening, eye examination and management of COPD) where we also found statistically significant differences. A lack of gender influence was observed only for influenza immunisation and for beta-blocker usage.

The size of this gender effect proved to be notable. A high proportion (AR~total~=5.9%) of missed care events could be attributed to this gender effect. More than 144 000 care events per year were missed (out of 2 600 827 expected events) due to gender effect among patients of male GPs in Hungary. Primarily, missed lipid (59 723 missed laboratory investigations) and serum creatinine measurements (52 130 missed laboratory investigations) were responsible for this impact. Missed examinations among patients with diabetes mellitus (9801 missed HbA1c measurements and 7686 missed eye examinations) and missed breast cancer screenings (13 285 screening tests) had a secondary, but significant, contribution.

Comparison with other studies {#s4-2}
-----------------------------

Others found similar gender differences in the management of diabetes[@R8] and cancer[@R8] screening. In addition, several studies have found an association between the management of hypertension and the gender of the physician. Female GPs tend to reach the blood pressure and lipid-level treatment goals more often[@R42] and tend to focus better on cardiovascular risk factor control.[@R15] Altogether, a positive association was observed between female gender and better quality of PHC in our investigation, in line with international experiences. Besides, our findings are consistent with other studies found that relatively low percentage of the variance is attributable to physicians on process measures after adjusting for characteristics of the physician, patient and practice.[@R44]

Strength and limitations {#s4-3}
------------------------

A strength of this study was that it covered the entire Hungarian population, avoiding selection bias in the analysis of the association between GP gender and PHC indicators and resulting in the representativeness of our results for the whole Hungarian PHC population. As a consequence, the main strength of our investigation was that it could estimate the population-level impact of the GP gender effect, which has rarely been investigated as reflected by a scarcity of relevant publications.

A limitation of the study is that we were not able to monitor the changes over time due to the cross-sectional design.

The relative educational level, which was used to indicate the educational attainment for GMPs, cannot be considered as a year-specific and GMP-specific indicator. The information on education was not available for the investigated year, and the relative educational level of the adults living in the settlement (settlement-specific) was considered, regardless of the number of GPs in one settlement.

Additionally, the fact that the range of variables in the NIHIFM database which could be included in the analysis is limited, careful interpretation is required. Although the analyses were controlled for GPs' and patients' age and gender, educational attainment, GMP practice size, types of settlement and regional location, there were confounding factors that were not included in our models, limiting the reliability of the presented risk measures. Selection of the GP may be affected by patients preferences and expectations, as patients have free choice of healthcare provider in Hungary. Since most of the GPs in Hungary are self-employed workers organising the provision on their own authority, the length of their working hours, the length of the consultation time and the availability of support staff were not measurable. The availability of support staff in solo practices or work in group practice could be an important factor in determining whether and how a patient will be treated.

Our analysis, which was based on data on solo GP practices, may differ from findings in group GP practices where professional cooperation with other providers may mitigate the effects of any non-clinical factors (eg, gender of GP).

Further research need {#s4-4}
---------------------

Our findings on impact of GP gender (mainly for HbA1c, serum creatinine and lipid measurement) suggest that further consideration of the effect is needed to identify the details and mechanisms behind the gender effect to improve the adequacy of targeted interventions. Patients with early stage diabetes mellitus are more cooperative with female GPs, but patients with advanced stages of the disease, realising the seriousness of the consequences, are more sensitive to male GP directions. The onset/duration of a chronic disease and accordingly the complex needs of patients may modify the gender effect.[@R46] Therefore, it would be worthwhile to investigate the potential influences on performance indicators that are differentiated according to the preferences[@R47] and type of their health problem.[@R50]

Furthermore, there is a possible extension of our presented investigation. Analysing outcome indicators on the prognosis of patients with chronic diseases in PHC is obviously required to more convincingly describe the public health impact of the GP gender effect.

Implications {#s4-5}
------------

Poor-quality healthcare services put a great burden on payers and society everywhere.[@R51] The effective utilisation of experiences of high-income countries[@R52] addressing gender differences in provision is crucial in low-income and middle-income countries such as Hungary. High-quality PHC is a shared goal of the patients, the GPs and the state.

According to our observations, a possible way to improve the quality of PHC is to raise awareness about the significance of the GPs' gender effect and its underlying causes. Keeping in mind that large sample size can detect even the smallest differences, the interpretation needs to consider that these small differences may have limited importance at population level; our results indicate the significance and urge the expansion of interventions aiming at improved communication skills of medical students and GPs, and at shifting the attitude of GPs. Incorporating practical knowledge on how the communication strategies and empathy in clinical practice influence the quality of services (which is often overlooked by medical students and practitioners) may facilitate the development of a patient-centred care culture.

It is well demonstrated that a behaviour change targeting improved patient outcomes is feasible by training physicians and medical students.[@R23] Since teaching patient-oriented communication skills to medical students increases their competency, as well as patients' satisfaction and health outcomes. Training in effective communication skills, embedded into the medical school curriculum, is widely recommended.[@R53] Our results suggest that the scope of this training should be supplemented by gender-related attitudes and behavioural features.

These findings can be utilised in gender impact assessment regarding the feminisation of the primary care physician workforce.[@R57]

Conclusions {#s5}
===========

Our results suggest the existence of a gender effect in Hungary on performance of GPs working in solo practices. Provision of guideline-recommended care was observed more often in patients of female GPs. The actual impact of the gender effect on the quality of services was found to be notable, emphasising that the communication style and attitude associated with female gender should be considered as factors influencing the quality of PHC and should be targeted accordingly in training of medical students and GPs. However, further studies involving a broader range of clinical and non-clinical factors are needed to allow more precise assessment of gender differences.
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